SCNX NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Scienture Holdings, Inc. · Healthcare · Pharmaceutical Retailers

Open interactive chart View report data Download investor PDF
Latest close 0.37 USD
-10.8% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -11.4% below the Trend Line and sits at 5.6% of its 52-week range. The latest completed week returned -10.8%, after a 2.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal; earnings are due in 13d.

Setup score 23 out of 100
Latest Close 0.37 USD 24 Jul 2026
1W Return -10.8% latest completed week
4W Return 2.5% short-term follow-through
12W Return -8.0% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.2x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 39.10% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -10.8% Latest completed week; four-week move 2.5%. Indicator stack 0/76 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 39.10% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 54/100 40 relevant articles in the latest sentiment read. Event risk 13d Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -11.4% below the Trend Line and sits at 5.6% of its 52-week range. The latest completed week returned -10.8%, after a 2.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.2x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1012-week average 0.07

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.10Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 2.5% over four weeks, -8.0% over 12 weeks, and -81.4% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-10.8%
4W2.5%
12W-8.0%
26W-27.6%
52W-81.4%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.41Latest activity-pressure read.
Pressure change7.7%Four-week change in activity pressure.
Leadership-47.37Latest relative-leadership reading.
RS change19.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 79% Model confidence 76%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength39/100Blend of value, momentum, and quality. Underlying universe rank 62; rank 1 is best.
Value45/100Relative valuation strength. Underlying universe rank 56; rank 1 is best.
Quality43/100Profitability and accounting quality. Underlying universe rank 58; rank 1 is best.
Momentum45/100Medium-term price momentum. Underlying universe rank 56; rank 1 is best.
Growth45/100Revenue and earnings growth. Underlying universe rank 56; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
31.4x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-88.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-20.7%
Gross profit retained from each unit of revenue.
Operating margin
-8456.8%
Operating profit retained from revenue.
Free-cash-flow margin
-2793.2%
Free cash flow generated from revenue.
Return on invested capital
-0.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
225.2%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.0%
Cash dividends relative to market value.
Buyback yield
-
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
89.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment54/100

Weighted news tone is neutral across 40 relevant articles.

14 positive · 20 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings13dNext report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-85.8%Distance below the 52-week high.
13-week volatility6.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+18.6%Week of 17 Apr.
Worst week-28.9%Week of 3 Apr.
Latest week-10.8%Week of 24 Jul.

Shape of recent returns

Strong gains8
Modest gains5
Flat weeks0
Modest losses3
Sharp losses10
Recent vol6.6%13-week weekly-return volatility.
Base vol30.1%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew16.0% / -11.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape20/100

Trend, activity pressure, participation, and risk combine to a 20/100 tape read.

 Indicator analysis31/100

Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.10; No reversal markers Next-Week ExpectancyNegative 39.10%

Next-week expectancy is negative with a 39.10% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors42/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 50 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment54/100

Weighted news tone is neutral across 40 relevant articles.

Enterprise value to EBITDA forward of Scienture Holdings, Inc. – NASDAQ:SCNX Insiders50/100

No recent insider transaction evidence is stored.

 Earnings13d

Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20260.37 USD-10.8%0.42 USD3.51 USD1.41-47.371.5MOff
17 Jul 20260.41 USD11.9%0.42 USD3.53 USD1.44-45.036.5MOff
10 Jul 20260.37 USD7.6%0.43 USD3.55 USD1.30-55.4269.6MOff
3 Jul 20260.34 USD-4.5%0.43 USD3.58 USD1.26-59.43815.9KOff
26 Jun 20260.36 USD-5.7%0.44 USD3.62 USD1.31-58.58981.7KOff
19 Jun 20260.38 USD1.0%0.45 USD3.66 USD1.47-58.852.2MOff
12 Jun 20260.38 USD5.0%0.46 USD3.69 USD1.57-58.953.7MOff
5 Jun 20260.36 USD-12.8%0.47 USD3.70 USD1.49-60.881.9MOff
29 May 20260.41 USD2.7%0.48 USD3.71 USD1.53-58.07731.6KOff
22 May 20260.40 USD-0.2%0.49 USD3.72 USD1.48-58.681.4MOff
15 May 20260.40 USD0.8%0.53 USD3.74 USD1.43-58.761.3MOff
8 May 20260.40 USD-0.3%0.53 USD3.75 USD1.37-59.843.4MOff
1 May 20260.40 USD-2.2%0.54 USD3.76 USD1.20-58.261.3MOff
24 Apr 20260.41 USD3.8%0.56 USD3.78 USD0.67-57.451.9MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.